The Mount Sinai Center for Healthcare Readiness operates within the Icahn School of Medicine at Mount Sinai, perfoming basic, clinical, epidemiological, and translational research to improve the lives of our patients—and of patients around the globe. Learn more about our recent studies and projects below:
Civilian Medical Responder Perspectives to a Federal Military Medical Deployment in New York City during the COVID-19 Pandemic
Icahn Mount Sinai conducted a qualitative research study to better understand the civilian experience and perceptions of coordination and management between the New York City civilian and the military health systems during an international public health emergency.
Military Response to Medical Crises-Consensus Recommendations for Military-Civilian Transitions of Care
Uniformed Services University and Icahn Mount Sinai hosted a consensus conference of civilian and military health care professionals to identify care transition best practices for future military-civilian responses.
National Disaster Medical System Omaha Pilot Site: Increased Capacity in a Two-Pronged Approach
This project aims to increase surge capacity and improve operational readiness to support the goals of the National Disaster Medical System (NDMS) Definitive Care Pilot Program in the Omaha area. The University of Nebraska Medical Center is collaborating with Icahn Mount Sinai to improve understanding of the financial impact of participation in NDMS by the civilian health care sector and provide guidance for policy and reimbursement strategies to offset costs incurred by civilian partners in the case of large-scale activations throughout the NDMS definitive care network, both regionally and nationally.
K12 Physician Scientist Award Program (PSA)
Sarah McCuskee, MD, MPhil, is a K12 Pediatric and Reproductive Environmental Health Sciences awardee through the National Institute of Environmental Health Sciences, exploring climate emergencies’ impact on sickle cell disease outcomes and progression. Her work leverages spatiotemporal environmental analysis in combination with sickle cell disease biomarkers, clinical data, and outcomes along the causal pathway, in two longitudinal cohorts.